Streptomycete endophytes from anti-diabetic medicinal plants of the Western Ghats inhibit alpha-amylase and promote glucose uptake

Letters in Applied Microbiology

Volumn 58, Issue 5, 2014, Pages 433-439

  Akshatha, V J ^a   Nalini, M S ^a   D'Souza, C ^a   Prakash, H S ^a  

^a UNIVERSITY OF MYSORE   (India)

Author keywords

Endophytic actinomycetes; Glucose uptake; Medicinal plants; Molecular characterization; Western Ghats; amylase inhibition

Indexed keywords

ALGAE; BACTERIA; GLUCOSE; POLYSACCHARIDES; RNA;

AGAR MEDIA; ALPHA AMYLASE; ANTIDIABETIC; ENDOPHYTIC ACTINOMYCETE; GLUCOSE UPTAKE; MEDICINAL PLANTS; MOLECULAR CHARACTERIZATION; STREPTOMYCETES; WESTERN GHATS; Α-AMYLASE INHIBITION;

AMYLASES;

ACARBOSE; AMYLASE; AMYLASE INHIBITOR; ANTIBIOTIC AGENT; CYCLOHEXIMIDE; RNA 16S; STREPTOMYCES LONGISPOROFLAVUS EXTRACT; UNCLASSIFIED DRUG;

BACTERIUM; BIOLOGICAL UPTAKE; BIOTECHNOLOGY; DIABETES; DISEASE CONTROL; ENDOPHYTE; FERMENTATION; GERMPLASM; GLUCOSE; IDENTIFICATION METHOD; INHIBITION; INHIBITOR; INOCULATION; LEAF; MEDICINAL PLANT; MOLECULAR ANALYSIS; STEM;

ACTINOBACTERIA; AGAR MEDIUM; ANTIDIABETIC ACTIVITY; ARTICLE; BIODIVERSITY; COLORIMETRY; CONTROLLED STUDY; ENDOPHYTE; ENZYME INHIBITION; FERMENTATION; GLUCOSE TRANSPORT; HEMIDIAPHRAGM; HUMAN; IC 50; INDIA; LEUCAS CILIATA; MEDICINAL PLANT; MEDICINAL SPECIES; NUCLEOTIDE SEQUENCE; RAUWOLFIA DENSIFLORA; RNA SEQUENCE; ROOM TEMPERATURE; STANDARD; STREPTOMYCES; SWINE;

INDIA; WESTERN GHATS;

ACTINOBACTERIA (CLASS); LEUCAS; RAUVOLFIA DENSIFLORA; STREPTOMYCES; STREPTOMYCES LONGISPOROFLAVUS; STREPTOMYCES SP.; SUS;

ENDOPHYTIC ACTINOMYCETES; GLUCOSE UPTAKE; MEDICINAL PLANTS; MOLECULAR CHARACTERIZATION; WESTERN GHATS; Α-AMYLASE INHIBITION;

ALPHA-AMYLASES; ANIMALS; BIOLOGICAL ASSAY; ENDOPHYTES; HYPOGLYCEMIC AGENTS; INDIA; MOLECULAR SEQUENCE DATA; PLANT EXTRACTS; PLANT LEAVES; PLANT STEMS; PLANTS, MEDICINAL; STREPTOMYCES; SWINE;

EID: 84898896959     PISSN: 02668254     EISSN: 1472765X     Source Type: Journal    
DOI: 10.1111/lam.12209     Document Type: Article

References (29)

1. Bailey, C.J. and Day, C. (1989) Traditional plant medicines as treatment for diabetes. Diabetes Care 12, 553-564.
2. De Melo, E.B., Gomes, A.D.S. and Carvalho, I. (2006) α- and β-Glucosidase inhibitors: chemical structure and biological activity. Tetrahedron 62, 10277-10302.
3. Diamond, J. (2003) The double puzzle of diabetes. Nature 423, 599-602.
4. El Ashry, E.S.H., Rashed, N. and Shobier, A.H. (2000) Glycosidase inhibitors and their chemotherapeutic value. Part 1. Pharmazie 55, 251-262.
5. Fisher, P.J., Petrini, O. and Lappin-Scott, H.M. (1992) The distribution of some fungal and bacteria endophytes in Maize (Zea mays L.). New Phytol 122, 299-305.
6. Franco, O.L., Rigden, D.J., Melo, F.R. and Grossi-de-Sá, M.F. (2002) Plant α-amylase inhibitors and their interaction with insect α-amylases. Eur J Biochem 269, 397-412.
7. Grover, J.K., Yadav, S. and Vats, V. (2002) Medicinal plants of India with anti-diabetic potential. J Ethnopharmacol 81, 81-100.
8. Iwasa, T., Yamamoto, H. and Shibata, M. (1970) Studies on validamycins, new antibiotics. I. Streptomyces hygroscopicus var. limoneus nov. var., validamycin-producing organism. J Antibiot 23, 595-602.
9. Iwasa, T., Higashide, E. and Shibata, M. (1971) Studies of validamycins, new antibiotics. 3. Bioassay methods for the determination of validamycins. J Antibiot 24, 114-118.
10. Jayasri, M.A., Radha, A. and Mathew, T.L. (2009) α-amylase and α-glucosidase inhibitory activity of Costus pictus D. Don in the management of diabetes. J Herb Med Toxicol 3, 91-94.
11. Kameda, Y., Asano, N., Yoshikawa, M. and Matsui, K. (1980) Valienamine as an α-glucosidase inhibitor. J Antibiot 33, 1575-1576.
12. Katsumata, M., Kaji, Y., Takada, R. and Dauncey, M.J. (2007) Nutritional regulation of GLUT expression, glucose metabolism and intramuscular fat content in porcine muscle. Asian-australas J Anim Sci 20, 1297-1304.
13. Lechevalier, H. (1989) A practical guide to generic identification of actinomycetes. In Bergeys's Manual of Systematic Bacteriology Volume 4. eds Williams, S.T., Sharpe, E.M. and Holt, G.J. pp. 2344-2347. USA.
14. 7N aminocyclitol family of natural products. Nat Prod Rep 20, 137-166.
15. de Meyts, P., Roth, J., Neville, D.M., Gavin, J.R. and Lesniak, M.A. (1973) Insulin interactions with its receptors: experimental evidence for negative co operativity. Biochem Biophys Res Commun 55, 154-161.
16. Mohan, V. (2004) Why are Indians more prone to diabetes? J Assoc Physicians India 52, 468.
17. Mukherjee, P.K., Maiti, K., Mukherjee, K. and Houghton, P.J. (2006) Leads from Indian medicinal plants with hypoglycemic potentials. J Ethanopharmacol 106, 1-28.
18. Namiki, S., Kangouri, K., Nagate, T., Hara, H., Sugita, K. and Omura, S. (1982a) Studies on the alpha-glucoside hydrolase inhibitor, adiposin. II. Taxonomic studies on the producing microorganism. J Antibiot 35, 1156-1159.
19. Namiki, S., Kangouri, K., Nagate, T., Hara, H., Sugita, K. and Omura, S. (1982b) Studies on the alpha-glucoside hydrolase inhibitor, adiposin. I. Isolation and physicochemical properties. J Antibiot 35, 1234-1236.
20. Rang, H.P., Dale, M.M., Ritter, J.M. and Moore, P.K. (2003) Pharmacology. 5 edn. 382. Churchill Livingstone.
21. Schmidit, D.D., Frommer, W., Junge, B., Muller, L., Wingender, W., Truscheit, E. and Schafer, D. (1977) α -Glucosidase inhibitors. Naturwissenschaften 64, 535-536.
22. Shirling, E.B. and Gottleib, D. (1966) Methods of characterization of Streptomyces species. Int J Syst Bacteriol 16, 313-340.
23. Suthindhiran, K., Jayasri, M.A. and Kannabiran, K. (2009) α-glucosidase and α-amylase inhibitory activity of Micromonospora sp. VTTSDK3 (EU551238). Int J Biol 6, 115-120.
24. Truscheit, E., Frommer, W., Junge, B., Muller, L., Schmidt, D.D. and Wingender, W. (1981) Chemistry and Biochemistry of Microbial -Glucosidase Inhibitors. Angew Chem Int Ed Engl 20, 744-761.
25. Vallance-Owen, J. and Hurlock, B. (1954) Estimation of plasma-insulin by the rat diaphragm method. Lancet 1, 68-70.
26. World Health Organization Consultation. (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Report of a WHO Consultation Geneva.
27. Xiao, Z., Storms, R. and Tsang, A. (2006) A quantitative starch-iodine method for measuring alpha-amylase and gluco-amylase activities. Anal Biochem 351, 146-148.
28. Yokose, K., Ogawa, K., Sano, T., Watanabe, K., Maruyama, H.B. and Suhara, Y. (1983) New α-amylase inhibitor, Trestatins I. Isolation, characterization and biological activities of Trestatins A, B and C. J Antibiot 36, 1157-1165.
29. Yokose, K., Ogawa, M. and Ogawa, K. (1984) New α-amylase inhibitor, Trestatins III. Structure determination of New Trestatin Components Ro 09-0766, Ro 09-0767 and Ro 09-0768. J Antibiot 37, 182-186.